Canine parainfluenza type 2 bronchiolitis increases histamine responsiveness in beagle puppies.
Histamine hyperresponsiveness with viral bronchiolitis may depend on previous exposures to viruses or to other pathogens. We studied 32 outbred beagle puppies 80 to 155 days of age who were raised in isolation and who were specific pathogen-free. Puppies were inoculated with canine parainfluenza type 2 (CPI2, n = 8), Bordetella bronchiseptica (Bb, n = 7), or both CPI2 and Bb (CPI2-Bb, n = 9). Control puppies (C, n = 8) were not inoculated. The puppies were anesthetized with sodium thiopental (5 mg/kg) and chloralose (80 mg/kg) and were ventilated mechanically. Lung resistance (RL), dynamic lung compliance (Cdyn), functional residual capacity (FRC), and responsiveness to aerosolized histamine were measured 3 days prior to inoculation (Day -3), on the day of inoculation (Day 0), and on Days 3-4, 6, 8-10, and 12-14 after inoculation. Histamine responsiveness was measured as: (1) the concentration of histamine base that increased RL to 150% (PC 150% RL) or decreased Cdyn to 75% (PC 75% Cdyn) of the response to saline (RL sal and Cdyn sal, respectively), and (2) the change in RL or Cdyn after inhalation of 11 mg/ml of histamine when compared with RL sal and Cdyn sal. On Day 0 there were no significant (p greater than 0.05) differences among groups with regard to age-corrected weights, FRC, RL, Cdyn, or histamine responsiveness. Control puppies remained healthy, and their pulmonary function and histamine responsiveness did not change. CPI2-Bb puppies increased RL and decreased FRC on Day 3-4, and were moderately ill and histamine-hyperresponsive on Day 3-4 and on Day 6.(ABSTRACT TRUNCATED AT 250 WORDS)
Lemen
R J
RJ
Department of Pediatrics, University of Arizona, Tucson 85724.
Quan
S F
SF
Witten
M L
ML
Sobonya
R E
RE
Ray
C G
CG
Grad
R
R
D000403:Airway Resistance / Q000187:drug effects; D000818:Animals; D001885:Bordetella Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology; D001988:Bronchiolitis / Q000473:pathology / Q000503:physiopathology; D001990:Bronchiolitis, Viral / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D004285:Dogs; D005260:Female; D005652:Functional Residual Capacity / Q000187:drug effects; D006632:Histamine / Q000494:pharmacology*; D008168:Lung / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology*; D008170:Lung Compliance / Q000187:drug effects; D008297:Male; D010223:Parainfluenza Virus 2, Human; D018184:Paramyxoviridae Infections / Q000150:complications / Q000473:pathology / Q000503:physiopathology*; D013047:Specific Pathogen-Free Organisms
D006632:Histamine